Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-23,609
Closed -$3.11M 405
2017
Q3
$3.11M Buy
23,609
+20,153
+583% +$2.71M 0.34% 100
2017
Q2
$460K Sell
3,456
-5,156
-60% -$696K 0.05% 420
2017
Q1
$1.16M Buy
+8,612
New +$1.12M 0.07% 395
2016
Q4
Sell
-125,659
Closed -$15.7M 827
2016
Q3
$15.7M Buy
125,659
+117,360
+1,414% +$15.4M 0.74% 10
2016
Q2
$1.15M Sell
8,299
-44,188
-84% -$5.73M 0.05% 431
2016
Q1
$6.62M Buy
52,487
+12,900
+33% +$1.64M 0.4% 49
2015
Q4
$5.02M Buy
+39,587
New +$4.91M 0.41% 44
2014
Q4
Sell
-12,126
Closed -$1.17M 480
2014
Q3
$1.17M Buy
+12,126
New +$1.1M 0.47% 39
2013
Q4
Sell
-9,850
Closed -$805K 312
2013
Q3
$805K Buy
+9,850
New +$832K 0.25% 93

Other funds holding CLX

Clinton Group's CLX Position: Q4 2017 in Review

Clinton Group sold out of Clorox (CLX) in Q4 2017, closing a stake of 23,609 shares — an estimated $3.11M sold.

Clinton Group first reported a position in CLX in Q3 2013 and held it in 9 quarters. The position peaked at $15.7M in Q3 2016. 932 funds tracked by Wall St. Rank hold CLX as of Q4 2017.

  • Clinton Group reported no remaining Clorox position as of Q4 2017 after selling out during the quarter.
  • Clinton Group sold 23,609 Clorox shares in Q4 2017, an estimated $3.11M.
  • Clinton Group first reported a position in Clorox in Q3 2013 and held it in 9 quarters.
  • Clinton Group's Clorox position peaked at $15.7M in Q3 2016.
  • 932 funds tracked by Wall St. Rank held Clorox as of Q4 2017.

Based on Clinton Group's 13F filing for Q4 2017, filed 14 Feb 2018.